HOME  ADDRESS ABSTRACTS PROGRAM CONFERENCE REGISTRATION HOTEL TIANJIN TOUR FORM 中文版

   

notice board

　

 　

INVITED SPEAKERS

Webster Cavenee, Ph.D.

Albert Deisseroth,

M.D.,Ph.D.

Jan E.Schnitzer, Ph.D.

Gregory N.Fuller, M.D.,Ph.D.

Stanley R.Hamilton, M.D.

Ilya Shmulevich, Ph.D.

Jeremy Squire, Ph.D.

Wei Zhang, Ph.D.

Li Jia, Ph.D.

Je Ho Lee, M.D.,Ph.D.

Chang Hun Rhee, M.D.Ph.D.

Tong-Hua Liu, M.D.

Shu-Jun Cheng, Ph.D.

Yan Sun, Ph.D.

Dao-Pei Lu, M.D.

Jian-Ren Gu, Ph.D.

Bing-Quan Wu, M.D.

Shu Zheng, M.D.

Xi-Shan Hao, M.D.

 　
　
INVITED SPEAKERS
Webster Cavenee,Ph.D. Member,National Academy of Siciences, Director,Ludwig Insititute for Cancer Research USA
Albert Deisseroth,M.D.,Ph.D. President, Sidney Kimmel Cancer Center, USA
Jan E.Schnitzer ,Ph.D. Sidney Kimmel Cancer Center, USA
Gregory N.Fuller,M.D.,Ph.D. Chief,Neuropathology, The University of Texas M.D.Anderson Cancer Center, USA
Stanley R.Hamilton,M.D. Head Division, Pathology and Lab Medicine,the University of Texas, M.D. Anderson Cancer Center, USA
Ilya Shmulevich,Ph.D. Assistant Professor,The University of Texas,M.D. Anderson Cancer Center, USA
Jeremy Squire,Ph.D. Director, Department of Pathology,Toronto University Ontario Cancer Institute, Canada
Wei Zhang,Ph.D. Director,Cancer Genomics Core Lab,The University of Texas M.D. Anderson Cancer Center, USA
Li Jia,Ph.D. Lecturer, Royal London Hospital Medican School, UK
Je Ho Lee,M.D.,Ph.D. Director, Clinical Cancer Research Center,Samsung Cancer Center, Seoul, Korea
Chang Hun Rhee,M.D.Ph.D. Chairman, Neurosurgery, Korea Cancer Center Hospital Seoul, Korea
Tong-Hua Liu,M.D. Professor, Department of Pathology, Chinese Academy of Medical Science, Beijing, China
Shu-Jun Cheng,Ph.D. Member, Chinese Academy of Engineering,Professor, Chinese Academy of Medical Science Cancer Institute & Hospital, Beijing, China
Yan Sun,Ph.D. Member, Chinese Academy of Engineering,Professor, Chinese Academy of Medical Science Cancer Institute & Hospital, Beijing, China
Dao-Pei Lu,M.D. Member, Chinese Academy of Engineering,Professor, Beijing University People’s Hospital, Beijing, China
Jian-Ren Gu,Ph.D. Member, Chinese Academy of Engineering,  Professor, Shanghai Cancer Institute, Shanghai, China
Bing-Quan Wu,M.D. Professor, Beijing University Cancer Reserch Center, Beijing,China
Shu Zheng,M.D. Professor, Zhejiang University Cancer Hospital & Institute Zhejiang, China
Xi-Shan Hao,M.D. Professor, Tianjin Medical University, Director, Tianin Cancer Institute & Hospital, Tianjin, China

　

Monday, 21 October 2002

Time

                             Content

0800-1630

                              Registration

1700-1800

                             Opening Ceremony

1800-2000

                            Welcome Reception

 Tuesday, 22 October 2002

Time

Speaker

Topic

0800-0830

Keynote Speaker

Webster Cavenee,Ph.D

Targeting mutant Receptors in Cancer

0830-0900

Shu-Jun Cheng, M.D.

Molecular and Cytogenetic Alterations in Non-Small Cell Lung Cancer in China

0900-0930

Gregory Fuller, M.D.,Ph.D.

High Throughput Cancer Marker Identification and Confirmation

0930-1000

Bing-Quan Wu, Ph.D.

Moleculer Diagnosis of Cancer

1000-1015

 Tea Break/Poster Presentations  

1015-1045

Jan E.Schnitzer, Ph.D.  

Accessible functional proteomics:Mapping the molecular heterogeneity of endothelia and caveolae for transcytosis & tissue-targeted therapy in vivo  

1045-1115

Jian-Ren Gu, M.D.

Non-viral Gene Delivery System For Gene Therapy

1115-1145

Jeremy Squire, Ph.D.

Genomic Approaches to the Identification of New Prognostic Markers for Treatment Response in Leukemia

1145-1215

Yan Sun, M.D.

The Progress of Cancer Intervention

1215-1245

Wei Zhang, Ph.D.

Understanding  Cancer Using Genomic Approaches

1245-1400

Lunch                                                                 

1400-1430

Li Jia, Ph.D.

Role of BH3-only Proteins in the Treatment of  Cancer 

1430-1730

Platform  Session

1800-1900

                      Dinner       

 Wednesday 23 Oct.2002

 Time

Speaker

 Topic

0800-0830

Keynote Speaker

Stanley Hamilton, M.D.

Molecular and Genomics Basis of Colon Cancer

0830-0900

Xi-Shan Hao, M.D.

Cancer Vaccine

0900-0930

Ilya Shmulevich , Ph.D.

Genetic Networks and Identification of Intervention Targets

0930-1000

Tong-Hua Liu, M.D.,Ph.D.

Gene Therapy for Pancreatic Cancer

1000-1015

       Tea Break/Poster Presentation                                                 

1015-1045

Albert Deisseroth, M.D.,Ph.D.

Vecor Targeting of Cancer

1045-1115

Dao-Pei Lu, M.D.

Curative therapy of hematological malignancies (HM)

1115-1145

Je Ho Lee , M.D. ,Ph.D.

Gene Therapy of Ovarian Cancer

1145-1215

Shu Zheng,Ph.D.

The Progress in Colon-Recter Cancer in China

1215-1245

Chang Hun Rhee,M.D. ,Ph.D.

Anti-Angiogenesis Therapy of Cancer

1245-1400

     Lunch                                             

1400-1730

Platform Session

1800-2000

    Closing Ceremony and  Farewell Dinner